Amsterdam, Netherlands

Theodorus Jozef Maria Helmerhorst

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Theodorus Jozef Maria Helmerhorst: Innovator in HPV Treatment

Introduction

Theodorus Jozef Maria Helmerhorst is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of medical treatment, particularly in addressing HPV-induced intraepithelial neoplasia. His innovative approach has the potential to improve patient outcomes in the treatment of various anogenital neoplasias.

Latest Patents

Helmerhorst holds a patent for "Methods and means for the treatment of HPV induced intraepithelial neoplasia." This invention provides improved methods for treating virally induced intraepithelial neoplasias of the ano-genital tract, including vulvar, cervical, vaginal, penile, and anal intraepithelial neoplasias. The method involves determining T-cell reactivity for viral early antigens and subsequently applying local treatment with immune-modulating compounds if the subject tests positive for T-cell reactivity.

Career Highlights

Helmerhorst is affiliated with the Leiden University Medical Center, where he continues to advance research and treatment methodologies. His work focuses on enhancing immune responses to HPV antigens, which is crucial for effective treatment strategies.

Collaborations

He collaborates with esteemed colleagues such as Sjoerd Hendricus Van Der Burg and Rienk Offringa, contributing to a collective effort in the medical research community.

Conclusion

Theodorus Jozef Maria Helmerhorst's innovative work in the treatment of HPV-induced intraepithelial neoplasia showcases his commitment to improving healthcare outcomes. His contributions are vital in the ongoing battle against HPV-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…